Product information

Current status:

Marketed

Current status date:

2024-02-05

Original market date: ^{See footnote 1}

2024-02-05

Product name:

JAMP RIVAROXABAN

DIN:

02516314 Electronic product monograph is not available

Company:

JAMP PHARMA CORPORATION
1310 Rue Nobel
Boucherville
Quebec
Canada J4B 5H3

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

PRESCRIPTION

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B01AF01 RIVAROXABAN

Active ingredient group (AIG) number:^{See footnote5}

0152487003